BioCentury
ARTICLE | Clinical News

Avridi immediate-release oxycodone regulatory update

September 21, 2015 7:00 AM UTC

FDA’s Anesthetic and Analgesic Drug Products and Drug Safety and Risk Management advisory committees voted 23-1 against approval of Avridi abuse-deterrent immediate-release oxycodone from Purdue to treat moderate to severe pain where the use of an opioid analgesic is appropriate. Purdue said the PDUFA date is next quarter. ...